Endo International... Sound familiar? Earlier this August we posted a blog with a similar title “Endo International Settles Securities Settlement for $50 Million.”
So what’s the difference? Aside from $32.5 million.
The first settlement pertained to declining demand for Endo’s generic drugs and ... Read More